Rohini Sigireddi, MD
Cornea and External Diseases Specialist · Houston, TXNPI 1457811440
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Alcon at 31.5% of the total. 2025 is the largest year on record at $541, 4.5 times the $120 reported in 2023. That places this record below the midpoint for cornea and external diseases specialist clinicians in TX, where the typical reported total is $821.
Across 12 payments — averaging $70.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$268
- Rxsight Inc$147
- AbbVie$125
- Carl Zeiss Meditec, Inc.$106
- Dompe US, Inc.$100
- Bausch & Lomb Americas Inc.$42
- plus $62 from 2 others
What the payments were for
- Food & beverage$849100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 2 | $268 |
| Rxsight Inc | 1 | $147 |
| AbbVie | 1 | $125 |
| Carl Zeiss Meditec, Inc. | 1 | $106 |
| Dompe US, Inc. | 3 | $100 |
| Bausch & Lomb Americas Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $36 |
| Tarsus Pharmaceuticals, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$849 in reported general payments places this provider in the 50th percentile of 35 cornea and external diseases specialist providers in Texas.
See all cornea and external diseases specialist providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetazolamide ErAcetazolamide | 16 | $2,882 |
| Prednisolone Acetate | 33 | $1,300 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $319 |
| Ofloxacin | 13 | $178 |
Paid to pharmacies, not to this prescriber.
Other cornea and external diseases specialist in Houston
- Stella KimHouston$58K
- Elizabeth UriasHouston$5K
- Morgan FredellHouston$821
- Shazia AliHouston$677
- Ahmad KheirkhahHouston$301
- Benjamin ParkHouston$104
- Forrest SwannWaco$111K
- Rachel GelmanMcAllen$54K
- Ravi PatelRound Rock$9K
- Jeremy BartleyDallas$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.